Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8

International Journal of Cancer

Volumn 82, Issue 4, 1999, Pages 538-548

  Bergman, Ira ^a,b   Barmada, Mamdouha A ^a   Heller, Glenn ^c   Griffin, Judith A ^a   Cheung, Nai Kong V ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FILGRASTIM NEUPOGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GANGLIOSIDE ANTIBODY; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3F8; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SARGRAMOSTIM LEUKINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; CANCER INHIBITION; CELL ACTIVATION; CEREBROSPINAL FLUID; DOSE RESPONSE; DRUG PENETRATION; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LEPTOMENINX; MELANOMA; MENINGIOMA; NEUROBLASTOMA; NONHUMAN; PLEOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT; TUMOR CELL DESTRUCTION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MELANOMA; MENINGEAL NEOPLASMS; NEUROBLASTOMA; PROTEOCHONDROITIN SULFATES; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032837580     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990812)82:4<538::AID-IJC12>3.0.CO;2-7     Document Type: Article

References (41)

1. ANTHONY, D.C., BOLTON, S.J., FEAM, S. and PERRY, V.H., Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain, 120, 435-444 (1997).
2. BARROSO-ARANDA, J., SCHMID-SCHONBEIN, G.W., ZWEIFACH, B.W. and MATHISON, J.C., Polymorphonuclear neutrophil contribution to induced tolerance to bacterial lipopolysaccharide. Circul. Res., 69, 1196-1206 (1991).
3. BERGMAN, I., BARMADA, M.A., KEMP, S.S., GRIFFIN, J.A. and CHEUNG, N.K.V., A rat model of leptomeningeal human neoplastic xenografts. J. NeuroOncol., 34, 221-231 (1997)
4. BERGMAN, I., BURCKART, G.J., POHL, C.R., VENKATARAMANAN, R., BARMADA, M.A. and GRIFFIN, J.A., Pharmacokinetics of intrathecal administration of IgG and IgM antiganglioside antibodies in rats and monkeys. J. PET., 284, 111-115 (1998).
5. BERGMAN, I., POHL, C.R., VENKATARAMANAN, R., BURCKART, G.J., STABIN, M., BARMADA, M.A., GRIFFIN, J.A. and CHEUNG, N.K.V., Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats. Accepted for publication, J. Immunother., 22, 114-123 (1999).
6. 2: a preliminary report. J. NeuroOncol., 24, 109-122 (1995).
7. +T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol., 149, 3627-3635 (1992).
8. CHAMBERLAIN, M.C., New approaches to and current treatment of leptomeningeal metastases. Curr. Opin. Neurol., 7, 492-500 (1994).
9. CHAMBERLAIN, M.C. and KORMANIK, P.R., Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J. NeuroOncol., 35, 55-64 (1997a).
10. CHAMBERLAIN, M.C. and KORMANIK, P.R., Non-AIDS-related lymphomatous meningitis: combined modality therapy. Neurology, 49, 1728-1731 (1997b).
11. CHEUNG, N.K.V, SAARINEN, U.M., NEELY, J.E., LANDMEIER, B., DONOVAN, D. and COCCIA, P.F., Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res., 45, 2642-2649 (1985).
12. DISTASIO, J.A. and CHEUNG, N.K., Current therapies using monoclonal antibodies. II. Malignant disease. Compr. Ther., 18, 40-44 (1992).
13. DURANDO, M., FERNANDO, L., ASHTON, S., HALUSHKA, P. and COOK, J. Suppressed thromboxane production in endotoxin-desensitized THP-1 cells is not a results of decreased prostaglandin H synthase activity. Shock, 9, 359-363 (1998).
14. GREENAWAY, S., HENNIKER, A.J., WALSH, M. and BRADSTOCK, K.F., A pilot clinical trial of two murine monoclonal antibodies fixing human complement in patients with chronic lymphatic leukemia. Leukemia Lymphoma, 13, 323-331 (1994).
15. INOUE, M., KATO, H., MUKAI, S., KAWAHITO, Y., ASAI, K., KIMURA, S., YAMAMURA, Y., SANO, H., SUGINO, S. and KONDO, M., Recombinant human granulocyte colony-stimulating factor augments cytotoxicity of OK-432-induced polymorphonuclear leukocytes. Int. J. Immunopharmacol., 16, 19-28 (1994).
16. KANWAR, V.S. and CAIRO, M.S., Neonatal neutrophil maturation, kinetics, and function. In J.S. Abramson and J.G. Wheeler (eds). The neutrophil, pp. 1-21, IRL Press, Oxford (1993).
17. KITA, R., ENOKIHARA, H., NAGASHIMA, S., TSUNOGAKE, S., YAMATO, H., SAITO, K., FURUSAWA, S., SHISHIDO, H. and FUKUSHIMA, T., GM-CSF and eosinophil chemotactic factors in an acute lymphoblastic leukemia patient with eosinophilia. Acta Haematol., 90, 144-147 (1993).
18. KUSHNER, B.H. and CHEUNG, N.K.V., Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes. Cancer Res., 51, 4865-4870 (1991).
19. KUSHNER, B.H. and CHEUNG, N.K.V., Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. Blood, 79, 1484-1490 (1992).
20. LIST, J., MOSER, R.P., STEUER, M., LOUDON, W.G., BLACKLOCK, J.B. and GRIMM, E.A., Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (mr 55,000 protein). Cancer Res., 52, 1123-1128 (1992).
21. MIDORIKAWA, Y., YAMASHITA, T. and SENDO, F., Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selective depletion of neutrophils in vivo. Cancer Res., 50, 6243-6247 (1990).
22. MYKLEBUST, A.T., GODAL, A. and FODSTAD, O., Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer. Cancer Res., 54, 2146-2150 (1994).
23. OHIRA, H., UENO, T., TORIMURA, T., TANIKAWA, K. and KASUKAWA, R., Leukocyte adhesion molecules in the liver and plasma cytokine levels in endotoxin-induced rat liver injury. Scand. J. Gastroenterol., 30, 1027-1035 (1995).
24. OHTA, S., HONDA, A., TOKUTAKE, Y., YOSHIDA, H. and HANAI, N., Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3. Cancer Immunol. Immunother., 36, 260-266(1993).
25. PACKER, R.J., SIEGEL, K.R., SUTTON, L.N., LITMANN, P., BRUCE, D.A. and SCHUT, L., Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann. Neurol., 18, 217-221 (1985).
26. PASTAN, I.H., ARCHER, G.E., MCLENDON, R.E., FRIEDMAN, H.S., FUCHS, H.E., WANGE, Q.C., PAL, L.H., HERNDON, J. and BIGNER, D.D., Intrathecal administration of single-chain immunotoxin, LMB-7 [B3 (Fv)-PE38], produces cures of carcinomatous meningitis in a rat model. Proc nat Acad Sci. (Wash.), 92, 2765-2799 (1995).
27. PERICLE, F., KIRKEN, R.A., EPLING-BURNETTE, P.K., BLANCHARD, D.K. and DJEU, J.Y., Direct killing of interleukin-2-transfected tumor cells by human neutrophils. Int. J. Cancer, 66, 367-373 (1996).
28. RAGNHAMMAR, P., FRODIN, J.E., TROTTA, P.P. and MELLSTEDT, H., Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol. Immunother., 39, 254-262 (1994).
29. REALI, E., GUILIANA, A.L., SPISANI, S., MORETTI, S., GAVIOLI, R., MASUCCI, G., GAMBARI, R. and TRANIELLO, S., Interferon-γ enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW-11-16. Clin. Immunol. Immunopathol., 71, 105-112 (1994).
30. REALI, E., SPISANI, S., GAVIOLI, R., LANZA, F., MORETTI, S. and TRANIELLO, S., IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils. Immunol. Cell Biol., 73, 234-238 (1995).
31. SCHELD, W.M., Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms. Amer. J. Med., 76, 193-201 (1984).
32. SCHLOM J., Monoclonal antibodies in cancer therapy. In V.T. Devita, S. Hellman and S.A. Rosenberg (eds). Biological therapy of cancer: principles and practice, pp. 507-21, J.B. Lippincott Co, Philadelphia (1995).
33. SEINO, K.I., KAYAGAKI, N., OKUMURA, K. and YAGITA, H., Antitumor effect of locally produced CD95 ligand. Nature Med., 3, 165-171 (1997).
34. SHEN, L., GUYRE, P.M. and FANGER, M.W., Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J. Immunol., 139, 534-538 (1987).
35. STOPPACCIARO, A., MELANI, C., PARENZA, M., MASTRACCHIO, A., BASSI, C., BARONI, C., PARMIANI, G. and COLOMBO, M.P., Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon. J. exp. Med., 178, 151-161 (1993).
36. TAUB, D.D., Chemokine-leukocyte interactions: the voodoo that they do so well. Cytokine Growth Factor Rev., 1, 355-376 (1996).
37. TAYLOR, H.G., MILLS, E.L., CIAMPI, A., DUBERGER, R., WATTERS, G.V., GOLD, R., MACDONALD, N., and MICHAELS, R.H., The sequelae of Haemophilus influenzae meningitis in school-age children. N. Engl. J. Med., 323, 1657-1663 (1990).
38. URCH, C.E., GEORGE, A.J.T., STEVENSON, G.T., BOLOGNESI, A., STIRPE, F., WELLER, R. and GLENNIE, M.J., Intrathecal treatment of leptomeningeal lymphoma with immunotoxin. Int. J. Cancer, 47, 909-915 (1991).
39. VALERIUS, T., REPP, R., DEWIT, T.P.M., BERTHOLD, S., PLATZER, E., KALDEN, J.R., GRAMATZKI, M. and VAN DE WINKEL, J.G.J., Involvement of the high-affinity receptor for IgG (FcyRI;CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood, 82, 931-939 (1993).
40. YOKAYAMA, T., ODA, M., OGURA, S., HORIUCHI, T. and SEINO, Y., Relationship of interleukin-8 and colony-stimulating factors to neutrophil migration in aseptic meningitis. Acts Paediatr., 85, 303-307 (1996).
41. ZALUTSKY, M.R., MCLENDON, R.E., GARG, P.K., ARCHER, G.E., SCHUSTER, J.M. and BIGNER, D.D., Radioimmunotherapy of neoplastic meningitis in rats using an a-particle-emitting immunoconjugate. Cancer Res., 54, 4719-4725 (1994).